Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Mycoses 1Leukemia, Biphenotypic, Acute 1Diarrhea 1Bacterial Infections 1

Interventions

Filgrastim 4Etoposide 3Cytarabine 2Carboplatin 2pegfilgrastim 1liposomal amphotericin B 1Vincristine 1Thrombopoietin 1Thioguanine 1Taxes 1Radiotherapy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Moxifloxacin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Leucovorin 1Ifosfamide 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Epirubicin 1Doxorubicin 1Docetaxel 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neutropenia × Levofloxacin × Clear all
NCT01371656 2020-12-07

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Children's Oncology Group

Phase 3 Completed
624 enrolled 16 charts
LymphoidOther hematologic neoplasm

Bacterial Infections, Diarrhea, Mycoses, Neutropenia, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡